tradingkey.logo
tradingkey.logo
Search

Cogent Biosciences Inc

COGT
Add to Watchlist
38.930USD
-2.430-5.88%
Close 07-31 16:00ETQuotes delayed by 15 min
6.65BMarket Cap
LossP/E TTM

COGT Financials

See Cogent Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cogent Biosciences Inc Earnings Date

Latest Release
May 5, 2026
EPS / Forecast
-0.53/-0.54
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.16
-11.16%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-1.04%-0.53
-385.54%-0.59
8.23%-0.59
10.47%-0.53
-7.99%-0.52
37.58%-0.12
0.25%-0.64
-0.74%-0.59
10.91%-0.49
-1541.35%-0.19
---0.64
---0.59
---0.55
---0.01
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
Net Profit
-44.64%-86.02M
-555.46%-88.42M
-14.58%-80.93M
-3.27%-60.88M
-29.07%-59.47M
20.10%-13.49M
-27.54%-70.63M
-33.75%-58.95M
-19.41%-46.08M
-1917.20%-16.88M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
96.64%-837.00K
-83.72%-35.06M
-111.05%-34.93M
-161.20%-30.63M
78.48%-24.91M
61.82%-19.08M
-123.85%-16.55M
Debt to assets ratio
--24.71%
--23.77%
--10.39%
--15.99%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
Operating profit
-38.27%-103.61M
-34.94%-99.49M
-10.53%-83.36M
-17.39%-75.58M
-20.08%-74.93M
-26.63%-73.73M
-26.58%-75.41M
-36.75%-64.39M
-44.33%-62.40M
-33.11%-58.23M
-61.81%-59.58M
-31.32%-47.09M
-37.62%-43.24M
-70.61%-43.74M
-85.79%-36.82M
-107.35%-35.85M
-145.45%-31.42M
-123.81%-25.64M
-92.62%-19.82M
-133.58%-17.29M
Net Profit
-44.64%-86.02M
-555.46%-88.42M
-14.58%-80.93M
-3.27%-60.88M
-29.07%-59.47M
20.10%-13.49M
-27.54%-70.63M
-33.75%-58.95M
-19.41%-46.08M
-1917.20%-16.88M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
96.64%-837.00K
-83.72%-35.06M
-111.05%-34.93M
-161.20%-30.63M
78.48%-24.91M
61.82%-19.08M
-123.85%-16.55M
Current assets
247.12%877.80M
207.06%910.36M
16.31%397.24M
-33.78%245.01M
-42.77%252.88M
9.49%296.47M
19.44%341.53M
10.60%369.97M
95.30%441.90M
2.19%270.77M
-3.53%285.95M
1.16%334.52M
16.19%226.27M
19.01%264.97M
42.85%296.42M
49.39%330.68M
-16.09%194.73M
-9.10%222.63M
55.53%207.50M
824.26%221.35M
Total current liabilities
17.57%57.98M
14.80%63.95M
17.34%62.25M
46.04%58.42M
34.43%49.32M
45.96%55.71M
52.79%53.05M
55.31%40.00M
73.70%36.69M
42.16%38.17M
47.42%34.72M
-6.87%25.76M
18.13%21.12M
57.22%26.85M
40.95%23.55M
102.16%27.66M
116.93%17.88M
30.42%17.08M
-16.96%16.71M
65.45%13.68M
Total assets
218.19%903.01M
185.94%937.61M
10.92%425.93M
-36.08%274.82M
-40.39%283.80M
4.61%327.90M
8.04%384.02M
9.57%429.94M
80.89%476.11M
4.20%313.44M
7.20%355.45M
7.19%392.37M
27.23%263.20M
29.61%300.81M
53.94%331.56M
60.19%366.05M
-12.94%206.87M
-7.50%232.09M
53.99%215.38M
635.84%228.52M
Total liabilities
355.71%295.31M
320.65%301.24M
78.02%123.47M
111.21%119.78M
20.50%64.80M
28.72%71.61M
31.99%69.36M
29.06%56.71M
35.68%53.78M
23.43%55.63M
26.26%52.55M
-5.84%43.94M
108.54%39.63M
151.70%45.08M
129.34%41.62M
197.02%46.67M
75.22%19.01M
10.21%17.91M
-23.79%18.15M
32.99%15.71M
Total equity
177.49%607.69M
148.31%636.37M
-3.88%302.46M
-58.46%155.04M
-48.15%219.00M
-0.59%256.29M
3.88%314.66M
7.12%373.22M
88.91%422.33M
0.81%257.80M
4.47%302.90M
9.09%348.43M
19.00%223.56M
19.40%255.74M
47.00%289.94M
50.08%319.38M
-17.15%187.86M
-8.73%214.18M
69.95%197.24M
1005.99%212.80M
Net operating income
-30.63%-86.88M
-30.59%-79.11M
-23.66%-64.29M
-27.73%-54.54M
-26.62%-66.51M
-37.46%-60.58M
-36.90%-51.98M
-33.17%-42.70M
-32.93%-52.53M
-49.86%-44.07M
-10.25%-37.97M
-21.21%-32.07M
-39.47%-39.52M
-41.54%-29.41M
-144.10%-34.44M
-111.46%-26.46M
-149.29%-28.33M
-121.83%-20.78M
-37.42%-14.11M
-50.30%-12.51M
Net investment
-152.55%-36.46M
-623.37%-322.77M
-357.61%-155.05M
110.53%8.91M
6545.50%69.38M
487.96%61.67M
166.48%60.19M
-8.97%-84.63M
-98.26%1.04M
-63.08%10.49M
40.26%-90.54M
-6688.55%-77.66M
13679.14%59.88M
6661.43%28.41M
-12930.44%-151.54M
-830.08%-1.14M
---441.00K
---433.00K
-113.81%-1.16M
---123.00K
Net financing
110.40%52.54M
2264011.54%588.67M
34734.46%217.37M
18548.05%47.23M
-88.33%24.97M
--26.00K
-37.60%624.00K
-100.16%-256.00K
48002.70%214.06M
-100.00%0.00
1.01%1.00M
-0.01%162.09M
222.46%445.00K
-99.17%315.00K
1700.00%990.00K
--162.12M
262.35%138.00K
-68.88%38.01M
-99.95%55.00K
-100.00%0.00

FAQs

What are the current assets of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its current assets were 910.36M, with a year-on-year change of 207.06.

What are the total assets of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its total assets of Cogent Biosciences Inc were 937.61M, with a year-on-year change of 185.94.

What are the total liabilities of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its total liabilities of Cogent Biosciences Inc were 301.24M, with a year-on-year change of 320.65.

What is the total equity of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its total equity of Cogent Biosciences Inc was 636.37M, with a year-on-year change of 148.31.

What is the net operating income of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its net operating income of Cogent Biosciences Inc was -333.36M, with a year-on-year change of -20.81.

What is the net investment of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its net investment of Cogent Biosciences Inc was -399.53M, with a year-on-year change of -1143.80.

What is the net financing of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its net financing of Cogent Biosciences Inc was 878.23M, with a year-on-year change of 309.53.

What is the Earnings Per Share (EPS) of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.16, with a year-on-year change of -11.16.

What is the net income of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its net income was -277.89M, with a year-on-year change of -37.96.

What is the Return on Equity (ROE) of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -80.24, with a year-on-year change of 31.59.

What is the Return on Assets (ROA) of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -51.99, with a year-on-year change of 34.85.

What is the operating profit of Cogent Biosciences Inc?

According to Cogent Biosciences Inc's FY2025 earnings report, its operating profit was -333.36M, with a year-on-year change of -20.81.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.